rs387907371
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM2PP3_StrongPP5_Very_Strong
The NM_001110556.2(FLNA):c.5217G>A(p.Thr1739Thr) variant causes a splice region, synonymous change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_001110556.2 splice_region, synonymous
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FLNA | NM_001110556.2 | c.5217G>A | p.Thr1739Thr | splice_region_variant, synonymous_variant | Exon 31 of 48 | ENST00000369850.10 | NP_001104026.1 | |
FLNA | NM_001456.4 | c.5193G>A | p.Thr1731Thr | splice_region_variant, synonymous_variant | Exon 30 of 47 | NP_001447.2 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 26
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 26
ClinVar
Submissions by phenotype
not provided Pathogenic:2
In silico analysis suggests this variant may impact gene splicing. In addition, RNA expression studies demonstrate that this variant activates a cryptic splice site, removing the last 16 amino acids in exon 31 (p.Val1724_Thr1739del) (PMID: 20598277); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis suggests this variant may impact gene splicing. In the absence of RNA/functional studies, the actual effect of this sequence change is unknown.; This variant is associated with the following publications: (PMID: 26061098, 25614868, 31919883, 15864382, 10982965, 9800904, 26059211, 30561107, 20598277) -
- -
Terminal osseous dysplasia-pigmentary defects syndrome Pathogenic:1Other:1
- -
- -
Melnick-Needles syndrome;C0265293:Frontometaphyseal dysplasia;C1844696:Oto-palato-digital syndrome, type II;C1848213:Heterotopia, periventricular, X-linked dominant Pathogenic:1
This sequence change affects codon 1731 of the FLNA mRNA. It is a 'silent' change, meaning that it does not change the encoded amino acid sequence of the FLNA protein. RNA analysis indicates that this variant induces altered splicing and likely results in the loss of 16 amino acid residue(s), but is expected to preserve the integrity of the reading-frame. This variant is not present in population databases (gnomAD no frequency). This variant has been observed in individuals with terminal osseous dysplasia with pigmentary skin defects within the clinical scope of X-linked otopalatodigital spectrum disorders (PMID: 20598277, 26061098, 30561107, 31919883). It has also been observed to segregate with disease in related individuals. This variant is also known as c.5217G>A. ClinVar contains an entry for this variant (Variation ID: 11775). Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Studies have shown that this variant results in the activation of a cryptic splice site in exon 30 (PMID: 20598277). For these reasons, this variant has been classified as Pathogenic. -
Heterotopia, periventricular, X-linked dominant Pathogenic:1
This variant was determined to be pathogenic according to ACMG Guidelines, 2015 [PMID:25741868]. This variant has been previously reported as disease-causing [PMID 20598277, 25614868, 26059211, 26061098, 30561107] -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at